BISPECIFIC ANTIBODY
An antibody that can be used as an anti-tumor agent and an anti-tumor agent comprises a molecule containing such an antibody. Such an antibody or a binding fragment thereof comprises: a heavy chain CDRH1 consisting of SEQ ID NO: 54, a heavy chain CDRH2 consisting of SEQ ID NO: 55, a heavy chain CDRH...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FURUZONO, Shinji SHIKU, Hiroshi SHINOZAKI, Naoya YATSU, Ayaka AKAHORI, Yasushi ICHIKAWA, Junya WATANABE, Ichiro OHTSUKA, Toshiaki NAKAYAMA, Makiko HASHIMOTO, Ryuji NAKAMURA, Kensuke TANAKA, Kento KOZUMA, Shiho |
| description | An antibody that can be used as an anti-tumor agent and an anti-tumor agent comprises a molecule containing such an antibody. Such an antibody or a binding fragment thereof comprises: a heavy chain CDRH1 consisting of SEQ ID NO: 54, a heavy chain CDRH2 consisting of SEQ ID NO: 55, a heavy chain CDRH3 consisting of SEQ ID NO: 56, a light chain CDRL1 consisting of SEQ ID NO: 57 or a light chain CDRL1 consisting of an amino acid sequence derived from SEQ ID NO: 57 in which amino acid 7 is W and/or amino acid 8 is K, a light chain CDRL2 consisting of SEQ ID NO: 58, and a light chain CDRL3 consisting of SEQ ID NO: 59 or a light chain CDRL3 consisting of an amino acid sequence derived from SEQ ID NO: 59 in which amino acid 2 is A or S. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023348616A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023348616A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023348616A13</originalsourceid><addsrcrecordid>eNrjZBB28gwOcHX2dPN0VnD0C_F08neJ5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGxsYmFmaGZo6GxsSpAgDQ2x8_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BISPECIFIC ANTIBODY</title><source>esp@cenet</source><creator>FURUZONO, Shinji ; SHIKU, Hiroshi ; SHINOZAKI, Naoya ; YATSU, Ayaka ; AKAHORI, Yasushi ; ICHIKAWA, Junya ; WATANABE, Ichiro ; OHTSUKA, Toshiaki ; NAKAYAMA, Makiko ; HASHIMOTO, Ryuji ; NAKAMURA, Kensuke ; TANAKA, Kento ; KOZUMA, Shiho</creator><creatorcontrib>FURUZONO, Shinji ; SHIKU, Hiroshi ; SHINOZAKI, Naoya ; YATSU, Ayaka ; AKAHORI, Yasushi ; ICHIKAWA, Junya ; WATANABE, Ichiro ; OHTSUKA, Toshiaki ; NAKAYAMA, Makiko ; HASHIMOTO, Ryuji ; NAKAMURA, Kensuke ; TANAKA, Kento ; KOZUMA, Shiho</creatorcontrib><description>An antibody that can be used as an anti-tumor agent and an anti-tumor agent comprises a molecule containing such an antibody. Such an antibody or a binding fragment thereof comprises: a heavy chain CDRH1 consisting of SEQ ID NO: 54, a heavy chain CDRH2 consisting of SEQ ID NO: 55, a heavy chain CDRH3 consisting of SEQ ID NO: 56, a light chain CDRL1 consisting of SEQ ID NO: 57 or a light chain CDRL1 consisting of an amino acid sequence derived from SEQ ID NO: 57 in which amino acid 7 is W and/or amino acid 8 is K, a light chain CDRL2 consisting of SEQ ID NO: 58, and a light chain CDRL3 consisting of SEQ ID NO: 59 or a light chain CDRL3 consisting of an amino acid sequence derived from SEQ ID NO: 59 in which amino acid 2 is A or S.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231102&DB=EPODOC&CC=US&NR=2023348616A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231102&DB=EPODOC&CC=US&NR=2023348616A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FURUZONO, Shinji</creatorcontrib><creatorcontrib>SHIKU, Hiroshi</creatorcontrib><creatorcontrib>SHINOZAKI, Naoya</creatorcontrib><creatorcontrib>YATSU, Ayaka</creatorcontrib><creatorcontrib>AKAHORI, Yasushi</creatorcontrib><creatorcontrib>ICHIKAWA, Junya</creatorcontrib><creatorcontrib>WATANABE, Ichiro</creatorcontrib><creatorcontrib>OHTSUKA, Toshiaki</creatorcontrib><creatorcontrib>NAKAYAMA, Makiko</creatorcontrib><creatorcontrib>HASHIMOTO, Ryuji</creatorcontrib><creatorcontrib>NAKAMURA, Kensuke</creatorcontrib><creatorcontrib>TANAKA, Kento</creatorcontrib><creatorcontrib>KOZUMA, Shiho</creatorcontrib><title>BISPECIFIC ANTIBODY</title><description>An antibody that can be used as an anti-tumor agent and an anti-tumor agent comprises a molecule containing such an antibody. Such an antibody or a binding fragment thereof comprises: a heavy chain CDRH1 consisting of SEQ ID NO: 54, a heavy chain CDRH2 consisting of SEQ ID NO: 55, a heavy chain CDRH3 consisting of SEQ ID NO: 56, a light chain CDRL1 consisting of SEQ ID NO: 57 or a light chain CDRL1 consisting of an amino acid sequence derived from SEQ ID NO: 57 in which amino acid 7 is W and/or amino acid 8 is K, a light chain CDRL2 consisting of SEQ ID NO: 58, and a light chain CDRL3 consisting of SEQ ID NO: 59 or a light chain CDRL3 consisting of an amino acid sequence derived from SEQ ID NO: 59 in which amino acid 2 is A or S.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBB28gwOcHX2dPN0VnD0C_F08neJ5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGxsYmFmaGZo6GxsSpAgDQ2x8_</recordid><startdate>20231102</startdate><enddate>20231102</enddate><creator>FURUZONO, Shinji</creator><creator>SHIKU, Hiroshi</creator><creator>SHINOZAKI, Naoya</creator><creator>YATSU, Ayaka</creator><creator>AKAHORI, Yasushi</creator><creator>ICHIKAWA, Junya</creator><creator>WATANABE, Ichiro</creator><creator>OHTSUKA, Toshiaki</creator><creator>NAKAYAMA, Makiko</creator><creator>HASHIMOTO, Ryuji</creator><creator>NAKAMURA, Kensuke</creator><creator>TANAKA, Kento</creator><creator>KOZUMA, Shiho</creator><scope>EVB</scope></search><sort><creationdate>20231102</creationdate><title>BISPECIFIC ANTIBODY</title><author>FURUZONO, Shinji ; SHIKU, Hiroshi ; SHINOZAKI, Naoya ; YATSU, Ayaka ; AKAHORI, Yasushi ; ICHIKAWA, Junya ; WATANABE, Ichiro ; OHTSUKA, Toshiaki ; NAKAYAMA, Makiko ; HASHIMOTO, Ryuji ; NAKAMURA, Kensuke ; TANAKA, Kento ; KOZUMA, Shiho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023348616A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FURUZONO, Shinji</creatorcontrib><creatorcontrib>SHIKU, Hiroshi</creatorcontrib><creatorcontrib>SHINOZAKI, Naoya</creatorcontrib><creatorcontrib>YATSU, Ayaka</creatorcontrib><creatorcontrib>AKAHORI, Yasushi</creatorcontrib><creatorcontrib>ICHIKAWA, Junya</creatorcontrib><creatorcontrib>WATANABE, Ichiro</creatorcontrib><creatorcontrib>OHTSUKA, Toshiaki</creatorcontrib><creatorcontrib>NAKAYAMA, Makiko</creatorcontrib><creatorcontrib>HASHIMOTO, Ryuji</creatorcontrib><creatorcontrib>NAKAMURA, Kensuke</creatorcontrib><creatorcontrib>TANAKA, Kento</creatorcontrib><creatorcontrib>KOZUMA, Shiho</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FURUZONO, Shinji</au><au>SHIKU, Hiroshi</au><au>SHINOZAKI, Naoya</au><au>YATSU, Ayaka</au><au>AKAHORI, Yasushi</au><au>ICHIKAWA, Junya</au><au>WATANABE, Ichiro</au><au>OHTSUKA, Toshiaki</au><au>NAKAYAMA, Makiko</au><au>HASHIMOTO, Ryuji</au><au>NAKAMURA, Kensuke</au><au>TANAKA, Kento</au><au>KOZUMA, Shiho</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BISPECIFIC ANTIBODY</title><date>2023-11-02</date><risdate>2023</risdate><abstract>An antibody that can be used as an anti-tumor agent and an anti-tumor agent comprises a molecule containing such an antibody. Such an antibody or a binding fragment thereof comprises: a heavy chain CDRH1 consisting of SEQ ID NO: 54, a heavy chain CDRH2 consisting of SEQ ID NO: 55, a heavy chain CDRH3 consisting of SEQ ID NO: 56, a light chain CDRL1 consisting of SEQ ID NO: 57 or a light chain CDRL1 consisting of an amino acid sequence derived from SEQ ID NO: 57 in which amino acid 7 is W and/or amino acid 8 is K, a light chain CDRL2 consisting of SEQ ID NO: 58, and a light chain CDRL3 consisting of SEQ ID NO: 59 or a light chain CDRL3 consisting of an amino acid sequence derived from SEQ ID NO: 59 in which amino acid 2 is A or S.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2023348616A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | BISPECIFIC ANTIBODY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A01%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FURUZONO,%20Shinji&rft.date=2023-11-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023348616A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |